DK1135193T3 - Middel til tumorterapi, som er baseret på liposomer, og som indeholder tamoxifen - Google Patents

Middel til tumorterapi, som er baseret på liposomer, og som indeholder tamoxifen

Info

Publication number
DK1135193T3
DK1135193T3 DK99964421T DK99964421T DK1135193T3 DK 1135193 T3 DK1135193 T3 DK 1135193T3 DK 99964421 T DK99964421 T DK 99964421T DK 99964421 T DK99964421 T DK 99964421T DK 1135193 T3 DK1135193 T3 DK 1135193T3
Authority
DK
Denmark
Prior art keywords
antineoplastic
liposome
agent containing
tumor therapy
therapy agent
Prior art date
Application number
DK99964421T
Other languages
Danish (da)
English (en)
Inventor
Reinhard Zeisig
Iduna Fichtner
Dietrich Arndt
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Application granted granted Critical
Publication of DK1135193T3 publication Critical patent/DK1135193T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99964421T 1998-12-04 1999-12-06 Middel til tumorterapi, som er baseret på liposomer, og som indeholder tamoxifen DK1135193T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855953 1998-12-04
PCT/DE1999/003952 WO2000033917A1 (fr) 1998-12-04 1999-12-06 Agent pour le traitement des tumeurs a base de liposomes et contenant du tamoxifene

Publications (1)

Publication Number Publication Date
DK1135193T3 true DK1135193T3 (da) 2002-12-02

Family

ID=7889947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99964421T DK1135193T3 (da) 1998-12-04 1999-12-06 Middel til tumorterapi, som er baseret på liposomer, og som indeholder tamoxifen

Country Status (9)

Country Link
US (1) US20030083313A1 (fr)
EP (1) EP1135193B1 (fr)
JP (1) JP2002531534A (fr)
AT (1) ATE226843T1 (fr)
DE (2) DE19959689A1 (fr)
DK (1) DK1135193T3 (fr)
ES (1) ES2185418T3 (fr)
PT (1) PT1135193E (fr)
WO (1) WO2000033917A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
KR101066804B1 (ko) 2002-07-30 2011-09-22 아에테르나 젠타리스 게엠베하 항종양 약제와 조합하여 사용하기 위한 알킬포스포콜린의 약물 제품
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
WO2006001035A2 (fr) * 2004-06-28 2006-01-05 Lifecare Innovations Pvt. Ltd. Composition liposomale synergique a base de tamoxifene pour application topique et son procede de preparation
EP1797427A4 (fr) * 2004-09-22 2009-04-08 Odyssey Thera Inc Procedes pour identifier de nouveaux medicaments chefs de file et nouvelles utilisations therapeutiques pour des medicaments connus
PT1827379E (pt) * 2004-10-19 2011-03-23 Max Planck Gesellschaft Formulações contendo alquilfosfocolinas usando novos portadores de carga negativa
EP1745788A1 (fr) 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipides pour le traitement du cancer et de la cachexie
EP1800684A1 (fr) * 2005-12-20 2007-06-27 Zentaris GmbH Nouveaux alkylphospholipides et leur utilisation
JP5232009B2 (ja) * 2005-12-19 2013-07-10 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用
DE102007008484A1 (de) * 2007-02-19 2008-08-21 Epo Experimentelle Pharmakologie & Onkologie Berlin-Buch Gmbh Pharmazeutische Zubereitung zur Bekämpfung von Metastasen
US20090088393A1 (en) * 2007-09-28 2009-04-02 Zomanex, Llc Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
WO2011123691A1 (fr) 2010-03-31 2011-10-06 Keryx Biopharmaceuticals, Inc. Périfosine et capécitabine en tant que traitement combiné du cancer
EP2667848A1 (fr) * 2011-01-28 2013-12-04 Koninklijke Philips N.V. Véhicules pour la libération locale de promédicaments hydrophiles
CN110037987B (zh) * 2018-01-15 2021-07-13 北京斯利安药业有限公司 一种枸橼酸他莫昔芬脂质体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0152379A3 (fr) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Procédé pour la préparation de compositions pharmaceutiques contenant des liposomes unilamellaires
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
DE4408011C1 (de) * 1994-03-10 1995-11-02 Max Delbrueck Centrum Pharmazeutisches Mittel zur Tumortherapie
DE19822509A1 (de) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Edelfosin zur Behandlung von Hirntumoren
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen

Also Published As

Publication number Publication date
JP2002531534A (ja) 2002-09-24
ATE226843T1 (de) 2002-11-15
EP1135193A1 (fr) 2001-09-26
DE59903276D1 (de) 2002-12-05
WO2000033917A1 (fr) 2000-06-15
DE19959689A1 (de) 2000-06-08
PT1135193E (pt) 2003-01-31
ES2185418T3 (es) 2003-04-16
US20030083313A1 (en) 2003-05-01
EP1135193B1 (fr) 2002-10-30

Similar Documents

Publication Publication Date Title
DK1135193T3 (da) Middel til tumorterapi, som er baseret på liposomer, og som indeholder tamoxifen
DE69923181D1 (de) Temperatursensitive liposomale formulierung
DE69530368D1 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
BR9915008A (pt) Composição de xampu, e, processo para preparação da mesma
NO984524D0 (no) Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer
PT892638E (pt) Formulacao topica de vitamina d a base de lipossomas
EA199900715A1 (ru) Липидные комплексы и липосомы совершенно нерастворимых комплексов платины
EA200000711A1 (ru) 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, СПОСОБ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ЭТИ 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, И ИХ ПРИМЕНЕНИЕ ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
ES2153053T3 (es) Liposomas de eter-lipido y su uso terapeutico.
ATE276742T1 (de) Stabile partikuläre komplexe lamellarer struktur mit neutraler oder negativer gesamtladung
NO20023139L (no) Liposomer som inneholder en forbindelse i supermettet lösning
DE69425750D1 (de) Zweiphasige multilamellare lipidvesikel
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
AR028333A1 (es) Antegenos de leishmania para la terapia y el diagnnstico de leishmaniasis
ES2071995T3 (es) Composicion para la activacion de macrofagia.
EA199900750A1 (ru) Водная фармацевтическая композиция, включающая активный ингредиент, в высшей степени нерастворимый в воде
NO20011406D0 (no) Immunogene liposompreparater
AR018321A1 (es) Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
UY26510A1 (es) " biblioteca de sustancias, procedimiento para su preparación y el uso de esta biblioteca de sustancias para la investigación de sustancias activas."
ES2236291T3 (es) Pirrolo(2,1-b)(1,3)benzotiazepinas y su uso para la preparacion de medicamentos con actividad antipsicotica.
DE19880842D2 (de) Niedrigdosierte 15-Desoxyspergualin-Präparate